DOJ Subpoenas Merck Over Avelox, Integrilin Marketing
The U.S. Department of Justice has subpoenaed Merck & Co. Inc. for information on its marketing practices for heart medication Integrilin and antibiotic Avelox and is investigating one of its subsidiaries...To view the full article, register now.
Already a subscriber? Click here to view full article